Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I do not see any link. I cannot access the post you are referring to. Could you please just cut and paste it into your reply?
tia!
What value would there be to investors if licensing agreement is extended?
Thanks for that info! Encouraging!
I’d be happier if those posts said they like Elite’s even better! The Teva formulation is still out there (under a different name) so i wonder if the reason everyone is being given Elite’s brand is that it costs less. That would certainly be good for Eltp!
i was just reporting statements people had made on online forums, saying that such-and-such generic brand fillers made them sick. They did not name the fillers but they did name the brands. My earlier post gives link to one such forum. Teva was one of the disliked brands. Check it out for yourself if you are interested.
Big differences among generics due to allowed fillers and quantities thereof. Many patients report headaches and nausea from currently available generic brands.
Hopefully, ELTP’s formulation will get it right! If they do, and patients choose ELTP’s formulation above all others,
the news will quickly get out, which will translate to $$$$$$$$$ for ELTP!
My question is: is there a Lannett authorized generic (different product from ELTP)?
Is there a Lannett authorized Adderall? If so, would that be a different product than ELTP generic Adderall that’s merely being distributed by Lannett?
I’m asking because Lannett authorized is getting some very bad reviews from some users due to additives they say are “really bad” and that there’s a lot more of the additive in the Lannett than in other brands, and also less of the meds.
There are big differences in the additives among the different generics.
VERY IMPORTANT: dozens of Adderall patients tell their experiences with different generic formulations. Bottom line: generics are not created equal, there are big differences among generics and users of generic versions of Adderall are mostly unhappy with what’s available.
So, if ELTP gets it right, this info will be widely shared by users!
https://www.additudemag.com/forums/topic/adderall-name-brand-vs-generic/
Actually, the word "tentative" refers to the speakers, not to the topics. So, if a listed "tentative" speaker can't present the results for some reason, another speaker could do it.
Look at the volume! A lot of people clearly think it’s good news and their last chance to get cheap shares!
(my one post of the day)
What’s happening with the ADF platform that’s said to be 95% cheaper than SOX? If we have that, why worry about SOX?
(my one allowed post for the day)
ADF’s are intended to keep non-addicts, (i.e. regular patients in pain) from getting started/hooked on their legitimate pain meds in the first place. If someone specifically wants to get high, they will choose heroin, fentanyl or non-ADF opioid meds. No one is gonna be seeking out an ADF for the sole purpose of getting high. Way too much trouble and expense. Ditto for taking a whole bottle of ADFs. Everyone (including the FDA!) knows this!
How is this bad news? Sounds like good news to me!
ESTIMATED Study completion Date: November 2019
ACTUAL Primary Completion Date: November 2018
Sounds like they completed the study a year earlier than estimated.
There's a 100% difference for lawsuits depending on if opioid is ADF or not. Lawsuits only target regular (easily abused, non-ADF)kind.
Although ELTP did make a couple of non-ADF, their real specialty in the opioid market is ADF! Crystal clear!
That's easy: NO SELLERS!!! Why? Because we know something big and good is coming our way soon so we are holding on to our shares!!!
There is no retail shorting of ELTP, and only minimal amounts of shorting by mms, as has been thoroughly shown in good DD previous posts.
Weezuhl,
Do you consider it a fantasy that Sungen or its parent company would buy Elite?
Do you agree that Nasrat must sell the company in order to cash out his shares?
How else if not via a buyout?
Pipeline, pipeline, pipeline is where it’s at! The more the merrier for the company that will BUY OUT eltp and pay us investors (not traders) BIG $$$$$$$$$!
What Naz cares about is building the company, not today’s share price. Traders are irrelevant to him, as they should be. When the company is sufficiently built up through its growing pipeline and partnerships (plus possible wildcard Isradipine) it will be bought out and all of us who are patient will make a lot of money. That time is coming probably fairly soon, within a couple of years at most.
Furthermore, he is not "keeping the share price low". How, exactly, would he even do that? However, that is being done by mms' blatant manipulation.
NASDAQ2020--how many such 500 K purchases? (with proof, please).
Weezuhl, i certainly hope you send that brilliant analysis to Dianne asap, if you haven't done so already! It's just possible that Naz and company haven't thought of that. Thank you.
Any suggestions for what Naz could realistically do to get FDA to tell him exactly what they now require to move SOX forward?
There's gotta be a decent alternative to simply waiting for FDA to reply! It’s been way too long, so surely (?) it is not out of line for Naz to contact them and ask politely for attention?!!
Also, how about a barrage of requests from many of us to Dianne for live Q+A in future CCs?
Realistically, is there anything Naz can do to move FDA to give us the guidance we need to proceed on SOX?
(other than--or including—this): Hidden conflicts? Pharma payments to FDA advisers after drug approvals...
http://www.sciencemag.org/news/2018/07/hidden-conflicts-pharma-payments-fda-advisers-after-drug-approvals-spark-ethical
Why don't they use it for SequestOx?
Seems like it would be in BP’s best interest to buy out ELTP right now. (Would also be in the best interests of the public, since ELTP’s ADTs would be available probably much sooner).
The question is: given this bias against Elite by FDA and BP, can eltp overcome it by means of their truly good and needed drugs??? Also, wouldn’t it be to BP’s advantage to buy eltp now, including their patents, instead of just trying to keep eltp down?
Mazeppa, it sounds like you don't have much faith in ELTP. Do you believe that ELTP can rise far above .13 with approvals we are awaiting and 2 new patents? and Glenmark+Sungen partnerships?
If not, why not?
Is the "Unique Novel new ADF platform” what Sequest-ox new formulation is using?
Thank you for explaining. Hopefully, the MJ market will overcome this setback, OGI in particular!
Can someone please explain what accounts for the big drop????
If OGI is so great, why has PPS fallen so much?
btw toofun, i meant to thank you for posting cc info when i asked!
Purdue is pushing their opioids aggressively in other countries.
PLEASE POST CC INFO, like call-in number. thank you.
Massachusetts AG suing Purdue and current/former execs over oxycontin.
https://www.mass.gov/news/ag-healey-sues-purdue-pharma-its-board-members-and-executives-for-illegally-marketing-opioids
The top guy here ran Purdue. Granted he did very evil things, knowingly getting hundreds of thousands of people hooked on opioids. But maybe this is his way of repenting. In any case, he's got the $big$ connections and access to top scientists and lawyers and regulatory agencies. I have faith in the $company.
Does anyone think this is a real company? That has any chance of getting to .09 ever again????
SequestOx post-approval would not necessarily have to go through the whole scenario you paint. If SequestOx is approved--which seems likely, based on the excellent results of the pilot study, and which would validate the tech for Elite’s whole line of ANDAs--there could be a buyout within a fairly short time after approval, because potential acquirers would see how the whole pipeline would $benefit them.
It’s all about getting approval of SequestOx (and/or some other big $ drug). PPS means nothing until then (except to flippers) and proves nothing about the company.
Just the same as if ELTP were a gold mine that for twenty years was dead but suddenly a rich vein of gold is struck. Or an oil well that for fifteen years was dry as dust…until suddenly, on one ordinary unexpected day, great gushing plumes of oil shoot up! In both cases, PPS would shoot up right along with the new circumstances.
Same thing with ELTP—the exact time cannot be predicted. But it will happen. Soon, i hope.
But actually, there is one big difference in ELTP’s case, which is: we keep seeing progress both in drug development and in partnership with Sungen.
Nasdaq, wrt the abuse-deterrent meeting you posted: I called CBI to be sure if ELTP is or is not presenting. I was told they are not listed as presenting or attending. I called Dianne to ask why not. Left a message. This is very concerning, imo, intuitively.